Information Journal Paper
APA:
Copy. (2017). Targeting GPNMB with glembatumumab vedotin: current developments and future opportunities for the treatment of cancer. PHARMACOLOGY AND THERAPEUTICS, 179(-), 127-141. SID. https://sid.ir/paper/756406/en
Vancouver:
Copy. Targeting GPNMB with glembatumumab vedotin: current developments and future opportunities for the treatment of cancer. PHARMACOLOGY AND THERAPEUTICS[Internet]. 2017;179(-):127-141. Available from: https://sid.ir/paper/756406/en
IEEE:
Copy, “Targeting GPNMB with glembatumumab vedotin: current developments and future opportunities for the treatment of cancer,” PHARMACOLOGY AND THERAPEUTICS, vol. 179, no. -, pp. 127–141, 2017, [Online]. Available: https://sid.ir/paper/756406/en